Effect of time interval between surgery and preoperative chemoradiotherapy with 5-fluorouracil or 5-fluorouracil and oxaliplatin on outcomes in rectal cancer

Journal of Surgical Oncology

Volumn 96, Issue 3, 2007, Pages 207-212

  Dolinsky, C M ^a   Mahmoud, N N ^a   Mick, R ^b   Sun, W ^a   Whittington, R W ^a   Solin, L J ^a   Haller, D G ^a   Giantonio, B J ^a   O'Dwyer, P J ^a   Rosato, E F ^a   Fry, R D ^a   Metz, J M ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Combined modality; Neoadjuvant; Pathologic complete response

Indexed keywords

FLUOROURACIL; OXALIPLATIN; ANTINEOPLASTIC AGENT; PLATINUM COMPLEX;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; COMBINATION CHEMOTHERAPY; CONTINUOUS INFUSION; DISEASE FREE SURVIVAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PHOTON THERAPY; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RECTUM CANCER; RECTUM CARCINOMA; TREATMENT OUTCOME; TREATMENT RESPONSE; ADENOCARCINOMA; ADJUVANT THERAPY; CANCER STAGING; LYMPH NODE; MIDDLE AGED; MORTALITY; PATHOLOGY; RECTUM TUMOR; TIME;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; DISEASE-FREE SURVIVAL; FEMALE; FLUOROURACIL; HUMANS; LYMPH NODES; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; ORGANOPLATINUM COMPOUNDS; RECTAL NEOPLASMS; TIME FACTORS;

EID: 35448998473     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.20815     Document Type: Article

References (29)

1. Krook JE, Moertel CG, Gunderson LL, et al.: Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 1991;324:709-715.
2. Minsky BD, Cohen AM, Kemeny N, et al.: Enhancement of radiation-induced downstaging of rectal cancer by fluorouracil and high-dose leucovorin chemotherapy. J Clin Oncol 1992;10:79-84.
3. Mohiuddin M, Marks G: High dose preoperative irradiation for cancer of the rectum, 1976-1988. Int J Radiat Oncol Biol Phys 1991;20:37-43.
4. Rich TA, Skibber JM, Ajani JA, et al.: Preoperative infusional chemoradiation therapy for stage T3 rectal cancer. Int J Radiat Oncol Biol Phys 1995;32:1025-1029.
5. [Anonymous]: NIH consensus conference. adjuvant therapy for patients with colon and rectal cancer. JAMA 1990;264:1444-1450.
6. Chari RS, Tyler DS, Anscher MS, et al.: Preoperative radiation and chemotherapy in the treatment of adenocarcinoma of the rectum. Ann Surg 1995;221:778-786; discussion 786-787.
7. Chen ET, Mohiuddin M, Brodovsky H, et al.: Downstaging of advanced rectal cancer following combined preoperative chemotherapy and high dose radiation. Int J Radiat Oncol Biol Phys 1994;30:169-175.
8. Glehen O, Chapet O, Adham M, et al.: Long-term results of the lyons R 90-01randomized trial of preoperative radiotherapy with delayed surgery and its effect on sphincter-saving surgery in rectal cancer. Br J Surg 2003;90:996-998.
9. Grann A, Minsky BD, Cohen AM, et al.: Preliminary results of preoperative 5-fluorouracil. low-dose leucovorin, and concurrent radiation therapy for clinically resectable T3 rectal cancer. Dis Colon Rectum. 1997;40:515-522.
10. Kapiteijn E, Marijnen CA, Nagtegaal ID, et al.: Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001;345:638-646.
11. Sauer R, Becker H, Hohenberger W, et al.: Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004;351:1731-1740.
12. Minsky BD, Cohen AM, Kemeny N, et al.: Combined modality therapy of rectal cancer: Decreased acute toxicity with the preoperative approach. J Clin Oncol 1992;10:1218-1224.
13. Garcia-Aguilar J, Hernandez de Anda E, Sirivongs P, et al.: A pathologic complete response to preoperative chemoradiation is associated with lower local recurrence and improved survival in rectal cancer patients treated by mesorectal excision. Dis Colon Rectum 2003;46:298-304.
14. Ruo L, Tickoo S, Klimstra DS, et al.: Long-term prognostic significance of extent of rectal cancer response to preoperative radiation and chemotherapy. Ann Surg 2002;236:75-81.
15. Kaminsky-Forrett MC, Conroy T, Luporsi E, et al.: Prognostic implications of downstaging following preoperative radiation therapy for operable T3-T4 rectal cancer. Int J Radiat Oncol Biol Phys 1998;42:935-941.
16. Rodel C, Martus P, Papadoupolos T, et al.: Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. J Clin Oncol 2005;23:8688-8696.
17. Francois Y, Nemoz CJ, Baulieux J, et al.: Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: The lyon R 90-01randomized trial. J Clin Oncol 1999;17:2396.
18. Berger C, de Muret A, Garaud P, et al.: Preoperative radiotherapy (RT) for rectal cancer: Predictive factors of tumor downstaging and residual tumor cell density (RTCD): Prognostic implications. Int J Radiat Oncol Biol Phys 1997;37:619-627.
19. Moore HG, Gittleman AE, Minsky BD, et al.: Rate of pathologic complete response with increased interval between preoperative combined modality therapy and rectal cancer resection. Dis Colon Rectum 2004;47:279-286.
20. Pucciarelli S, Toppan P, Friso ML, et al.: Complete pathologic response following preoperative chemoradiation therapy for middle to lower rectal cancer is not a prognostic factor for a better outcome. Dis Colon Rectum 2004;47:1798-1807.
21. Stein DE, Mahmoud NN, Anne PR, et al.: Longer time interval between completion of neoadjuvant chemoradiation and surgical resection does not improve downstaging of rectal carcinoma. Dis Colon Rectum 2003;46:448-453.
22. Bipat S, Glas AS, Slors FJ, et al.: Rectal cancer: Local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging - A meta-analysis. Radiology 2004;232:773-783.
23. Aschele C, Friso ML, Pucciarelli S, et al.: A phase I-II study of weekly oxaliplatin, 5-fluorouracil continuous infusion and preoperative radiotherapy in locally advanced rectal cancer. Ann Oncol 2005;16:1140-1146.
24. Carraro S, Roca EL, Cartelli C, et al.: Radiochemotherapy with short daily infusion of low-dose oxaliplatin, leucovorin, and 5-FU in T3-T4 unresectable rectal cancer: A phase II IATTGI study. Int J Radiat Oncol Biol Phys 2002;54:397-402.
25. Freyer G, Bossard N, Romestaing P, et al.: Addition of oxaliplatin to continuous fluorouracil, 1-folinic acid, and concomitant radiotherapy in rectal cancer: The lyon R 97-03phase I trial. J Clin Oncol 2001;19:2433-2438.
26. Gerard JP, Chapet O, Nemoz C, et al.: Preoperative concurrent chemoradiotherapy in locally advanced rectal cancer with high-dose radiation and oxaliplatin-containing regimen: The lyon R 0-04phase II trial. J Clin Oncol 2003;21:1119-1124.
27. Loi S, Ngan SY, Hicks RJ, et al.: Oxaliplatin combined with infusional 5-fluorouracil and concomitant radiotherapy in inoperable and metastatic rectal cancer: A phase I trial. Br J Cancer 2005;92:655-661.
28. Gerard JP, Bonnetain F, Conroy T, et al.: Preoperative (preop) radiotherapy (RT) {+/-} 5 FU/folinic acid (FA) in T3-T4 rectal cancers. J Clin Oncol 2005;23: (suppl; abstr 3504).
29. Dolinsky CM, Mahmoud NN, Mick R. et al.: Improved pathologic complete response rates after preoperative chemoradiotherapy for rectal cancer with 5-FU/oxaliplatin (5FU/OX) compared to 5-fluorouracil (5-FU) alone. J Clin Oncol 2006;24: (suppl; abstr 3567).